Benzinga's Top Upgrades, Downgrades For February 13, 2018

Top Upgrades

  • Piper Jaffray upgraded Analog Devices, Inc. ADI from Neutral to Overweight.. Analog Devices shares rose 1.12 percent to $86.00 in pre-market trading.
  • Morgan Stanley upgraded Plains All American Pipeline, L.P. PAA from Equal-Weight to Overweight. Plains All American shares rose 0.86 percent to $22.25 in pre-market trading.
  • Barclays upgraded Celgene Corporation CELG from Equal-Weight to Overweight. Celgene shares rose 0.54 percent to $92.00 in pre-market trading.
  • Jefferies upgraded Forum Energy Technologies Inc FET from Hold to Buy. Forum Energy fell 2.55 percent to close at $11.45 on Monday.
  • Analysts at Keefe Bruyette & Woods upgraded JPMorgan Chase & Co. JPM from Market Perform to Outperform. JPMorgan shares fell 0.24 percent to $111.47 in pre-market trading.
  • Analysts at Credit Suisse upgraded Quest Diagnostics Inc DGX from Neutral to Outperform. Quest Diagnostics shares rose 0.71 percent to close at $99.07 on Monday.
  • KeyBanc upgraded Paycom Software Inc PAYC from Sector Weight to Overweight. Paycom Software shares rose 1.46 percent to close at $84.51 on Friday.
  • Analysts at Bank of America upgraded NetApp Inc. NTAP from Neutral to Buy. NetApp shares gained 2.98 percent to $59.45 in pre-market trading.
  • Wedbush upgraded Beacon Roofing Supply, Inc. BECN from Neutral to Outperform. Beacon Roofing shares fell 0.87 percent to close at $54.59 on Monday.
  • Raymond James upgraded M.D.C. Holdings, Inc. MDC from Market Perform to Outperform. M.D.C. Holdings shares rose 0.48 percent to close at $29.61 on Monday.


Top Downgrades

  • Wells Fargo downgraded CSRA Inc CSRA from Outperform to Market Perform. CSRA shares fell 0.10 percent to $40.35 in pre-market trading.
  • Morgan Stanley downgraded Eversource Energy ES from Overweight to Equal-Weight. Eversource Energy shares rose 0.95 percent to close at $57.53 on Monday.
  • Barclays downgraded Weatherford International Plc WFT from Overweight to Equal-Weight. Weatherford shares dropped 0.87 percent to close at $2.86 on Monday.
  • Bank of America downgraded AvalonBay Communities Inc AVB from Buy to Neutral. AvalonBay Communities shares fell 0.54 percent to close at $158.75 on Monday
  • Morgan Stanley downgraded BP plc (ADR) BP from Overweight to Equal-Weight. BP shares rose 0.13 percent to $39.92 in pre-market trading.


Top Initiations

  • B. Riley initiated coverage on Health Insurance Innovations Inc HIIQ with a Buy rating. The price target for Health Insurance Innovations is set to $38. Health Insurance Innovations shares closed at $22.80 on Monday.
  • Analysts at Citic Securities initiated coverage on Tesla Inc TSLA with a Buy rating. The price target for Tesla is set to $425. Tesla shares closed at $315.73 on Monday.
  • Piper Jaffray initiated coverage on Nine Energy Service, Inc. NINE with an Overweight rating. The price target for Nine Energy Service is set to $35. Nine Energy Service shares closed at $23.50 on Monday.
  • Morgan Stanley initiated coverage on ADT Inc. ADT with an Overweight rating. The price target for ADT is set to $18. ADT shares closed at $12.68 on Monday.
  • Analysts at RBC Capital initiated coverage on AmeriCold Realty Trust COLD with an Outperform rating. The price target for AmeriCold Realty Trust is set to $22. AmeriCold Realty Trust closed at $17.53 on Monday.
  • BTIG Research initiated coverage on Summit Therapeutics PLC (ADR) SMMT with a Buy rating. The price target for Summit Therapeutics is set to $33. Summit Therapeutics shares closed at $10.80 on Monday.
  • Analysts at Mizuho initiated coverage on Spark Therapeutics Inc ONCE with a Buy rating. The price target for Spark Therapeutics is set to $79. Spark Therapeutics shares closed at $54.08 on Monday.
  • Cowen & Co. initiated coverage on Premier Inc PINC with a Market Perform rating. The price target for Premier is set to $35. Premier shares closed at $31.75 on Monday.
  • Mizuho initiated coverage on AveXis Inc AVXS with a Buy rating. The price target for AveXis is set to $147. AveXis shares closed at $111.90 on Monday.
  • Analysts at Ascendiant Capital initiated coverage on Novus Therapeutics Inc NVUS with a Buy rating. The price target for Novus Therapeutics is set to $7. Novus Therapeutics closed at $3.15 on Monday.

Posted In: Initiationstop upgradesUpgradesDowngradesInitiationPre-Market OutlookAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.